United States · Investor

Battelle Ventures

Last cheque observed Nov 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series BVentureSeries A

Cheques on record
0%of best year0cheques in 12 months, 32 on record
Since the last cheque4358days00hrs00min00sec
Median round$6.8MRounds led0 of 32Sole investor1 roundsExits6 from the portfolioMostly inUnited States, 100%
Pitch Battelle Ventures

Battelle Ventures highlights

  1. 01

    32 rounds on record

  2. 02

    Mostly Series B and Venture: 63% of its rounds

  3. 03

    Sole investor in 1 rounds, median $500K

  4. 04

    6 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Based in
Saginaw, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first32 appearances

  1. 2014

    1 round

  2. Nov
    BioNano GenomicsSeries C · US$53MWith 4 others
  3. 2013

    2 rounds

  4. Oct
    BioNano GenomicsSeries C · US · xconomy.com$10MWith 2 others
  5. Jan
    Micro Interventional DevicesSeries B · US · pevc.dowjones.com$3.5MWith 1 other
  6. 2012

    2 rounds

  7. Dec
    ProterroSeries A · US$3.5MWith 4 others
  8. Jul
    BioNano GenomicsSeries B · US · pevc.dowjones.com$10MWith 2 others
  9. 2011

    2 rounds

  10. Mar
    BioNano GenomicsSeries B · US · bionanogenomics.com$23MWith 3 others
  11. Feb
    NisticaSeries D · US · finsmes.com$5.5MWith 4 others
  12. 2010

    3 rounds

  13. Aug
    AldisVenture · US · houston.citybizlist.com$6.0MWith 3 others
  14. Mar
    NisticaSeries C · US · battelleventures.com$6.5MWith 4 others
  15. Jan
    HepregenGrant · US · deals.venturebeat.com$500KSole investor
  16. 2008

    5 rounds

  17. Sept
    HepregenSeries A · US · xconomy.com$3.0MWith 1 other
  18. Jul
    NuPatheSeries B · US$30MWith 6 others
  19. Jun
    NellOne TherapeuticsVenture · US$1.5MWith 1 other
  20. Mar
    BioNano GenomicsSeries A · US$5.1MWith 2 others
  21. Feb
    NisticaSeries B · US · njbiz.com$10MWith 5 others
  22. 2007

    7 rounds

  23. Dec
    Hi-G-TekVenture$5.5MWith 1 other
  24. Dec
    CDI BioscienceVenture · US · wistechnology.com$3.0MWith 1 other
  25. Oct
    AldisSeries A · US$3.8MWith 2 others
  26. Aug
    SypherlinkSeries B · US · sypherlink.com$3.5MWith 3 others
  27. May
    MetatomixSeries B · US · metatomix.com$7.0MWith 5 others
  28. Apr
    SuperprotonicSeries B · US$16MWith 6 others
  29. Feb
    ENDOVALVESeries B · US$8.0MWith 1 other
  30. 2006

    5 rounds

  31. Dec
    RemoteRealityVenture · US · homelandsecuritynewswire.net$7.3MWith 1 other
  32. Sept
    Hi-G-TekVenture · US · findarticles.com$10MWith 2 others
  33. Jul
    Rajant CorporationSeries B · US · rajant.com$3.3MWith 1 other
  34. May
    BioVigilant SystemsSeries A · US$6.7MWith 3 others
  35. May
    MetatomixVenture · US · metatomix.com$11MWith 5 others
  36. 2005

    4 rounds

  37. Dec
    Multispectral ImagingSeries B$8.8MWith 3 others
  38. Oct
    SmartSynchSeries C · US · thefreelibrary.com$12MWith 9 others
  39. Jun
    SypherlinkSeries A · US · columbus.bizjournals.com$3.5MWith 1 other
  40. Apr
    BattellePharmaVenture · US$14MWith 6 others
  41. 2004

    1 round

  42. Jul
    SafeViewSeries B · US$16MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed6 in all

NuPatheBought by Endo Health Solutions$105MDec 2013
SmartSynchBought by Itron$100MFeb 2012
MetatomixBought by Versata EnterprisesUndisclosedSept 2010
NuPatheListedUndisclosedAug 2010
Multispectral ImagingBought by AgiltronUndisclosedMay 2008
SafeViewBought by L-3 CommunicationsUndisclosedMar 2006

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Battelle Ventures. A count of rooms they were both in, not a relationship either has claimed.

Innovation Valley PartnersInvestment firm15rounds togetherDomain AssociatesVC firm4rounds togetherNovitas CapitalVC firm4rounds togetherDeclaration PartnersFamily office3rounds togetherReservoir Venture PartnersGrowth equity3rounds togetherTechnology Venture PartnersGrowth equity3rounds togetherApex Venture PartnersGrowth equity2rounds togetherDunrath CapitalPrivate equity2rounds togetherEquity Resources GroupVC firm2rounds togetherFujikuraCorporate VC2rounds togetherKT Venture GroupGrowth equity2rounds togetherL Capital PartnersVC firm2rounds together

Quick answers about Battelle Ventures

What does Battelle Ventures invest in?

Battelle Ventures invests most often at Series B and Venture (63% of the rounds on record).

How active is Battelle Ventures?

32 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2014.

How big are Battelle Ventures's cheques?

The median round it joins is $6.8M.

Does Battelle Ventures lead rounds?

Rarely, if at all: none of its 32 investments on record names it as the lead.

Where does Battelle Ventures invest?

Most of the companies it backs are in the United States (100%).

Is Battelle Ventures investing now?

No investments in the last 12 months; the latest was in Nov 2014.

Who does Battelle Ventures invest alongside?

Most often Innovation Valley Partners (15 rounds together), Domain Associates (4 rounds together) and Novitas Capital (4 rounds together).

What kind of investor is Battelle Ventures?

Battelle Ventures is a VC firm based in Saginaw, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it